Zobrazeno 1 - 10
of 17
pro vyhledávání: ''
Autor:
Lucile L. Adams-Campbell, Julie R. Palmer, Mireille Bright-Gbebry, Kepher H. Makambi, Lynn Rosenberg, Adana A.M. Llanos, Joy Ann Phillips Rohan
Publikováno v:
BMC Complementary and Alternative Medicine
BMC Complementary and Alternative Medicine, Vol 11, Iss 1, p 30 (2011)
BMC Complementary and Alternative Medicine, Vol 11, Iss 1, p 30 (2011)
Background Complementary and alternative medicine (CAM) use, including herbals and multivitamin supplements, is quite common in the U.S., and has been shown to be highest in breast cancer survivors. However, limited data are currently available for C
Autor:
Neil Piller, Andrew Williams, Denis Visentin, Maarten A. Immink, Tony Barnett, Annette Loudon
Publikováno v:
BMC Complementary and Alternative Medicine
We aimed to evaluate the effect of an 8-week yoga intervention on the shoulder and spinal actions of women with breast cancer-related arm lymphoedema. A randomised controlled pilot trial. The intervention group (n = 12) completed eight weeks of daily
Publikováno v:
BMC Complementary and Alternative Medicine
Background Secondary arm lymphoedema continues to affect at least 20% of women after treatment for breast cancer requiring lifelong professional treatment and self-management. The holistic practice of yoga may offer benefits as an adjunct self-manage
Publikováno v:
BMC Complementary and Alternative Medicine
Background During the past few years, there has been an increasing interest among the Traditional and Folk medical practitioners of Sri Lanka in the use of a decoction prepared from Flueggea leucopyrus (Willd.) for treating various cancers including
Autor:
Aya Zarif, Dania Hariri, Zeina Nahleh, Mohamad Alameddine, Arafat Tfayli, Yasmin Aridi, Romy Abi Fadel, Maya Khalil, Anas Mugharbel, Farah Naja
Publikováno v:
BMC Complementary and Alternative Medicine
Background Breast cancer patients are increasingly seeking Complementary and Alternative Medicine (CAM) therapies with the hope of alleviating the burden of the disease and improving their quality of life (QOL). The objective of this study was to ass
Autor:
Abdul Rahman Omar, Kian Lam Lim, M. Nadeem Akhtar, Swee Keong Yeap, Jamil Ismail, Wan Yong Ho, Chai Ling Ho, Noorjahan Banu Alitheen, Mohd Puad Abdullah, Nadiah Abu
Publikováno v:
BMC Complementary and Alternative Medicine
Background The kava-kava plant (Piper methysticum) is traditionally consumed by the pacific islanders and has been linked to be involved in several biological activities. Flavokawain B is a unique chalcone, which can be found in the roots of the kava
Autor:
Constance J. Temm, Victor Castillo, Shujie Cheng, Isaac Eliaz, Matt Welty, George E. Sandusky, Mark Alvarado, Daniel Sliva
Publikováno v:
BMC Complementary and Alternative Medicine
Background Tamoxifen (TAM) has been widely used for the treatment of estrogen receptor (ER)-positive breast cancer and its combination with other therapies is being actively investigated as a way to increase efficacy and decrease side effects. Here,
Autor:
Minakshi Mazumdar, Chinta Raveendar, Rathin Chakrabarty, Shravanti Mukherjee, Dewan Md Sakib Hossain, Uttam K. Ghosh, Gaurisankar Sa, Anil Khurana, Tanya Das, Sanhita Mukherjee, Chaturbhuj Nayek, Suchismita Mohanty, Shilpi Saha
Publikováno v:
BMC Complementary and Alternative Medicine
Background Complementary medicines, including homeopathy, are used by many patients with cancer, usually alongside with conventional treatment. However, the molecular mechanisms underneath the anti-cancer effect, if any, of these medicines have still
Publikováno v:
BMC Complementary and Alternative Medicine
Background S-allyl mercaptocysteine (SAMC), a water-soluble component derived from garlic, has been found to exert multi-antitumor activities. This study was to investigate the responsible molecular mechanisms of SAMC in human breast cancer cell line
Autor:
Jar-Yi Ho, Shu Pin Chen, Cheng-Ping Yu, Ying Hsin Chen, Yao Chin Hsu, Ren Jun Hsu, Jui Ming Liu, Jyh Cherng Yu, Chia Lynn Fu, Fung Wei Chang
Publikováno v:
BMC Complementary and Alternative Medicine
Background Breast cancer-related mortality increases annually. The efficacy of current breast cancer treatments is limited, and they have numerous side effects and permit high recurrence. Patients with estrogen receptor (ER)-negative or triple-negati